Data / Form D filings / Clementia Pharmaceuticals Inc.
Clementia Pharmaceuticals Inc.: Form D filing
Clementia Pharmaceuticals Inc., a pharmaceuticals company in Dorval, Quebec, Canada, filed a Form D with the SEC in 2015. The latest, on July 7, 2015, reports $60 million sold of a $60 million offering to 16 investors.
Find out what Clementia Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1375 TRANS-CANADA HIGHWAY, SUITE 200, Dorval, Quebec, Canada, H9P 2
- Phone
- (514) 940-3600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Year incorporated
- 2010
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1647320
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2015 | New notice | $59,999,141 | $59,999,141 | $0 | 16 | Jun 22, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Francois P. Nader | Director | |
| Donna Roy Grogan | Executive Officer | |
| Jean-Francois P. Pariseau | Executive Officer, Director | |
| Michael Roy Singer | Executive Officer | |
| David P. Bonita | Director | |
| Robert P. Heft | Director | |
| Clarissa Desjardins | Executive Officer, Director | |
| Eric P. Grinstead | Executive Officer | |
| Jeffrey Roy Packman | Executive Officer | |
| Allan P. Mandelzys | Director |
Every Form D from the week of Jul 6, 2015 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Clementia Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.